Analisis Senyawa Bioaktif Averrhoa bilimbi L. sebagai Penghambat Enzim Siklooksigenasi-2 secara In Siliko

Esti Mulatsari; Yati Sumiyati; Warni Warni

doi:10.35814/jifi.v21i1.1284

Esti Mulatsari Faculty of Pharmacy, University Pancasila
Yati Sumiyati Faculty of Pharmacy, University Pancasila
Warni Warni Faculty of Pharmacy, University Pancasila

DOI: https://doi.org/10.35814/jifi.v21i1.1284

Abstract

Averrhoa bilimbi L. is generally used as a food flavor enhancer and traditional medicine to treat inflammation, cancer sores, cough, fever, gout, rectal bleeding, and hemorrhoids. In vivo and in
vitro studies on Averrhoa bilimbi L. have shown anti-inflammatory activity, but the active compounds that play a role in anti-inflammatory activity have not been reported. This study aimed to analyze sixtyfour (64) bioactive compounds in the Averrhoa bilimbi L. plant as cyclooxygenase-2 (COX-2) enzyme inhibitors using in silico approach and predict the pharmacokinetic and toxicological profiles of each compound. The cyclooxygenase-2 enzyme is an enzyme that plays a role in the inflammatory process by converting arachidonic acid into prostaglandin. Increased prostaglandins will cause inflammation. The research method used molecular docking with the application of YASARA, PLANTS, Marvinsketch, Pymol, visualization with PLIP and prediction of ADMET with pkCSM. Control compound used celecoxib. The results showed that there were 13 test compounds that were predicted to have better COX-2 inhibitor activity than celecoxib with good pharmacokinetic properties. Erucic acid has the best pharmacokinetic and toxicity profile. Erucic acid has the potential to be developed as a cyclooxygenase-2 enzyme inhibitor drug.

References

1. Kementrian Kesehatan RI. Kepmenkes Nomor 381 Tahun 2007 tentang Kebijakan Obat Tradisional.pdf. (2007).

2. Deputi Menegristek Bidang Pendayagunaan dan Pemasyarakatan Ilmu Pengetahuan dan Teknologi. Belimbing ( Averrhoa carambola ). Bappenas 1–12 (2009).

3. Anggraini, T., Febrianti, F., Aisman & Ismanto, S. D. Black Tea with Averrhoa Bilimbi L Extract: A Healthy Beverage. Agric. Agric. Sci. Procedia 9, 241–252 (2016).

4. Patil, A. G., Koli, S. P. & Patil, D. A. Pharmcognostical standardization and HPTLC fingerprint of Averrhoa bilimbi (L.) fruits. Journal of Pharmacy Research vol. 6 145–150 (2013).

5. Kementerian Kesehatan Republik Indonesia. Acuan Ramuan Baku Obat Indonesia dari Tumbuhan Obat di Indonesia. (Kementerian Kesehatan RI, 2017).

6. Hasim, H., Arifin, Y. Y., Andrianto, D. & Faridah, D. N. Ekstrak Etanol Daun Belimbing Wuluh (Averrhoa bilimbi) sebagai Antioksidan dan Antiinflamasi. J. Apl. Teknol. Pangan 8, 86 (2019).

7. Suluvoy, J. K., K.M., S., Guruvayoorappan, G. C. & Berlin, B. G. Protective effect of Averrhoa bilimbi L. fruit extract on ulcerative colitis in wistar rats via regulation of inflammatory mediators and cytokines. Biomedicine and Pharmacotherapy vol. 91 1113–1121 (2017).

8. Miraj, A. J. et al. Evaluation of the analgesic and anti-inflammatory activities of methanolic extracts of the leaves of Averrhoa bilimbi leaves. Discov. Phytomedicine 6, 12 (2019).

9. Baratawidjaja, Karnen Garna & Rengganis, I. Imunologi Dasar Edisi Ke-11 (Cetakan ke-2). (Badan Penerbit Fakultas Kedokteran Universitas Indonesia, 2016).

10. Baghaki, S. et al. COX2 inhibition in the treatment of COVID-19: Review of literature to propose repositioning of celecoxib for randomized controlled studies. International Journal of Infectious Diseases vol. 101 29–32 at https://doi.org/10.1016/j.ijid.2020.09.1466 (2020).

11. Ahmed, Q. U. et al. Antiradical and Xanthine oxidase inhibitory activity evaluations of Averrhoa bilimbi L. Leaves and tentative identification of bioactive constituents through LC-QTOF-MS/MS and molecular docking approach. Antioxidants vol. 7 1–16 (2018).

12. Abraham, C. M. A Study on Phytochemical Constituents of Averrhoa. Indian Journal of Applied Research vol. 6 29–31 (2016).

13. Suluvoy, J. K. & Berlin Grace, V. M. Original Article : Phytochemical profile and free radical nitric oxide (NO) scavenging activity of Averrhoa bilimbi L. fruit extract. 3 Biotech vol. 7 1–11 (2017).

14. Kurup, S. B. & S, M. Protective potential of Averrhoa bilimbi fruits in ameliorating the hepatic key enzymes in streptozotocin-induced diabetic rats. Biomedicine and Pharmacotherapy vol. 85 725–732 (2017).

15. Protein 6COX, 3LN1. Available from: https://www.rcsb.org/structure/6COX Accessed on 26 October 2020.

16. Struktur Senyawa Belimbing Wuluh dan Senyawa Pembanding. 16. 2D Structure of Averrhoa bilimbi L. Bioactive Compounds and Control Compounds [Internet]. Available from: http://www.pubchem.ncbi.nlm.nih.gov/. Retrieved 26 October 2020.

17. Yuniarti, N., Ikawati, Z. & Istyastono, E. P. The importance of ARG513 as a hydrogen bond anchor to discover COX-2 inhibitors in a virtual screening campaign. Bioinformation 6, 164–166 (2011).

18. Sudha, K. N. et al. Virtual screening for novel COX-2 inhibitors using the ZINC database. Bioinformation vol. 2 325–329 (2008).

19. Purnomo, H. Kimia Komputasi Molecular Docking Plants Penambatan Molekul Plants (Protein-Ligand-Ant-System) (Ilmu Semut). (Pustaka Pelajar, 2011).

20. Rachmania, R. A. Validasi Protokol Skrining Virtual Dan Analisis Interaksi Inhibitor Antiproliferasi Sel Kanker Berbasis Bahan Alam Terhadap Reseptor Cyclin-Dependent Kinase 4 (Cdk 4). Media Farm. J. Ilmu Farm. 16, 21–40 (2019).

21. Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews vol. 64 4–17 (2012).

22. Harno Dwi Pranowo & Hetadi, A. K. R. Pengantar Kimia Komputasi. (Lubuk Agung Bandung, 2011).

23. Salentin, S., Schreiber, S., Haupt, V. J., Adasme, M. F. & Schroeder, M. PLIP: Fully automated protein-ligand interaction profiler. Nucleic Acids Research vol. 43 W443–W447 (2015).

24. Siswandono & Sukardjo, B. Kimia Medisinal. (Airlangga University Press, 2008).

25. Pires, D. E. V, Blundell, T. L. & Ascher, D. B. pkCSM : Predicting Small-Molecule Pharmacokinetic Properties Using Graph-based Signatures. Journal of Medicinal Chemistry vol. 58 4066–4072 (2015).

26. Hardjono, S. Prediksi Sifat Farmakokinetik, Toksisitas dan Aktivitas Sitotoksik Turunan N-Benzoil-N’-(4-fluorofenil) thiourea sebagai Calon Obat Antikanker melalui Pemodelan Molekul. Jurnal Ilmu Kefarmasian Indonesia vol. 14 246–255 (2017).

27. Li, J. J. Pharmacokinetics (ADME). in Medicinal Chemistry for Practitioners 133–224 (John Wiley & Sons, Inc, 2020). doi:10.1002/9781119607311.ch3.

28. Badan Pengawas Obat dan Makanan. Pedoman Uji Toksisitas Non Klinik Secara In Vivo. at (2014).

29. Calder, P. C. Fatty acids: Long-chain fatty acids and inflammation. Proceedings of the Nutrition Society vol. 71 284–289 (2012).

30. Liang, X. et al. Erucic acid from Isatis indigotica Fort. suppresses influenza a virus replication and inflammation in vitro and in vivo through modulation of NF-κB and p38 MAPK pathway. Journal of Pharmaceutical Analysis vol. 10 130–146 (2020).

Bioactive Compounds Analysis of Averrhoa bilimbi L. as Inhibitor of Cyclooxygenase-2 Enzyme using In Silico Approach

Abstract

References

Fakultas Farmasi Universitas Pancasila